Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of myMDteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
October 16, 2025
 · 
Be the first to react
myMDteam

Currently approved exon-skipping therapies target exons 44, 45, 51, and 53. Since your child has a 3-17 exon duplication, the currently available exon-skipping medications would not be effective treatments. It's important to discuss specific treatment options with your child's healthcare team since they will have detailed Show Full Answer

Currently approved exon-skipping therapies target exons 44, 45, 51, and 53. Since your child has a 3-17 exon duplication, the currently available exon-skipping medications would not be effective treatments. It's important to discuss specific treatment options with your child's healthcare team since they will have detailed knowledge of your child's specific genetic mutation. While exon-skipping therapy may not be an option right now, researchers are actively working on developing new versions of these treatments that target other exons. Your healthcare provider can discuss whether participating in clinical trials might be appropriate for your child, as well as other current treatment approaches to help manage symptoms and slow disease progression.

October 16, 2025

Related Questions

View All
A myMDteam Member asked a question 💭
New Delhi

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In